Methylphenidate place conditioning in adolescent rats: An analysis of sex differences and the dopamine transporter

Behavioural Brain Research

Volumn 257, Issue , 2013, Pages 215-223

  Cummins, Elizabeth D ^a   Griffin, Stephen B ^a   Burgess, Katherine C ^a   Peterson, Daniel J ^a   Watson, Bryce D ^a   Buendia, Matthew A ^b   Stanwood, Gregg D ^b   Brown, Russell W ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescence; Conditioned place preference; Dopamine transporter; Methylphenidate; Sex differences

Indexed keywords

DOPAMINE TRANSPORTER; METHYLPHENIDATE; SODIUM CHLORIDE;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BEHAVIORAL SENSITIZATION; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; FEMALE; JUVENILE ANIMAL; LEARNING; MALE; NERVE CELL PLASTICITY; NONHUMAN; NUCLEUS ACCUMBENS; PERINATAL PERIOD; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD; SEX DIFFERENCE;

ADOLESCENCE; CONDITIONED PLACE PREFERENCE; DOPAMINE TRANSPORTER; METHYLPHENIDATE; SEX DIFFERENCES;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, CLASSICAL; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MAZE LEARNING; METHYLPHENIDATE; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS;

EID: 84886431544     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.09.036     Document Type: Article

References (49)

1. Garland E.J. Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats. J Psychopharmacol 1998, 12:385-395.
2. Kollins S.H., MacDonald E.K., Rush C.R. Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacol Biochem Behav 2001, 68:611-627.
3. Volkow N.D., Ding Y., Fowler J.S., Wang G.J., Logan J., Gatley J.S., et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain. Arch Gen Psychiatry 1995, 52:456-463.
4. Volkow N.D., Wang G.J., Fowler J.S., Fischman M., Foltin R., Abumrad N.N., et al. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain. Life Sci 1999, 65:PL7-P12.
5. Volkow N.D., Swanson J.M. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry 2003, 160:1909-1918.
6. Dupont R.L., Coleman J.J., Bucher R.H., Wilford B.B. Characteristics and motives of college students who engage in nonmedical use of methylphenidate. Am J Addict 2008, 17:167-171.
7. Morton W.A., Stockton G.G. Methylphenidate abuse and psychiatric side effects. Prim Care Companion J Clin Psychiatry 2000, 2:159-164.
8. Bright G.M. Abuse of medications employed for the treatment of ADHD: results from a large-scale community survey. Medscape J Med 2008, 10:111.
9. Bardo M.T., Bevins R.A. Conditioned place preference: what does it add to our preclinical understanding of drug reward. Psychopharmacology (Berl) 2000, 153:31-43.
10. Wooters T.E., Walton M.T., Bardo M.T. Oral methylphenidate establishes a conditioned place preference in rats. Neurosci Lett 2011, 487:293-296.
11. Sellings L.H., McQuade L.E., Clarke P.B. Characterization of dopamine-dependent rewarding and locomotor stimulant effects of intravenously-administered methylphenidate in rats. Neuroscience 2006, 141:1457-1468.
12. Meririnne E., Kankaanpää A., Seppälä T. Rewarding properties of methylphenidate: sensitization by prior exposure to the drug and effects of dopamine D1- and D2-receptor antagonists. J Pharmacol Exp Ther 2001, 298:539-550.
13. de la Peńa I.C., Ahn H.S., Choi J.Y., Shin C.Y., Ryu J.H., Cheong J.H. Methylphenidate self-administration and conditioned place preference in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat. Behav Pharmacol 2011, 22:31-39.
14. Moll G.H., Hause S., Rüther E., Rothenberger A., Huether G. Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. J Child Adolesc Psychopharmacol 2001, 11:15-24.
15. Izenwasser S., Coy A.E., Ladenheim B., Loeloff R.J., Cadet J.L., French D. Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine. Eur J Pharmacol 1999, 373:187-193.
16. Roessner V., Sagvolden T., Dasbanerjee T., Middleton F.A., Faraone S.V., Walaas S.I., et al. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type. Neuroscience 2010, 167:1183-1191.
17. Nikolaus S., Antke C., Beu M., Kley K., Larisch R., Wirrwar A., et al. In-vivo quantification of dose-dependent dopamine transporter blockade in the rat striatum with small animal SPECT. Nucl Med Commun 2007, 28:207-213.
18. Bello N.T., Hajnal A. Acute methylphenidate treatments reduce sucrose intake in restricted-fed bingeing rats. Brain Res Bull 2006, 70:422-429.
19. Andersen S.L., Teicher M.H. Sex differences in dopamine receptors and their relevance to ADHD. Neurosci Biobehav Rev 2000, 24:137-141.
20. Andersen S.L. Changes in the second messenger cyclic AMP during development may underlie motoric symptoms in attention deficit/hyperactivity disorder (ADHD). Behav Brain Res 2002, 130:197-201.
21. Wooters T.E., Dwoskin L.P., Bardo M.T. Age and sex differences in the locomotor effect of repeated methylphenidate in rats classified as high or low novelty responders. Psychopharmacology (Berl) 2006, 188:18-27.
22. Becker J.B. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav 1999, 64:803-812.
23. Carroll M.E., Anker J.J. Sex differences and ovarian hormones in animal models of drug dependence. Horm Behav 2010, 58:44-56.
24. Devilbiss D.M., Berridge C.W. Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge. J Pharmacol Exp Ther 2006, 319:1327-1335.
25. Berridge C.W., Devilbiss D.M., Andrzejewski M.E., Arnsten A.F., Kelley A.E., Schmeichel B., et al. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 2006, 60:1111-1120.
26. Brown R.W., Hughes B.A., Hughes A.B., Sheppard A.B., Perna M.K., Ragsdale W.L., et al. Sex and dose-related differences in methylphenidate adolescent locomotor sensitization and effects on brain-derived neurotrophic factor. J Psychopharmacol 2012, 26:1480-1488.
27. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 2000, 151:99-120.
28. Kalivas P.W., Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 1993, 13:266-275.
29. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 1986, 396:157-198.
30. Garland E.J. Intranasal abuse of prescribed methylphenidate. J Am Acad Child Adolesc Psychiatry 1988, 37:573-574.
31. Coetzee M., Kaminer Y., Morales A. Megadose intranasal methylphenidate (Ritalin) abuse in adult attention deficit hyperactivity disorder. Subst Abuse 2002, 23:165-169.
32. Stoops W.W., Glaser P.E., Rush C.R. Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate in humans: a dose-response analysis. Drug Alcohol Depend 2003, 71:179-186.
33. Griffiths R.R., Troisi J.R., Silverman K., Mumford G.K. Multiple-choice procedure: an efficient approach for investigating drug reinforcement in humans. Behav Pharmacol 1993, 4:3-13.
34. Gawin F.H. Cocaine addiction: psychology and neurophysiology. Science 1991, 251:1580-1586.
35. Fumagalli F., Cattaneo A., Caffino L., Ibba M., Racagni G., Carboni E., et al. Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate. Pharmacol Res 2010, 62:523-529.
36. Banerjee P.S., Aston J., Khundakar A.A., Zetterström T.S. Differential regulation of psychostimulant-induced gene expression of brain derived neurotrophic factor and the immediate-early gene Arc in the juvenile and adult brain. Eur J Neurosci 2009, 29:465-476.
37. Chelaru M.I., Yang P.B., Dafny N. Sex differences in the behavioral response to methylphenidate in three adolescent rat strains (WKY, SHR, SD). Behav Brain Res 2012, 226:8-17.
38. Brenhouse H.C., Napierata L., Kussmaul L., Leussis M., Andersen S.L. Juvenile methylphenidate exposure and factors that influence incentive processing. Dev Neurosci 2009, 31:95-106.
39. Wagner A.K., Kline A.E., Ren D., Willard L.A., Wenger M.K., Zafonte R.D., et al. Gender associations with chronic methylphenidate treatment and behavioral performance following experimental traumatic brain injury. Behav Brain Res 2007, 181:200-209.
40. Pickens C.L., Airavaara M., Theberge F., Fanous S., Hope B.T., Shaham Y. Neurobiology of the incubation of drug craving. Trends Neurosci 2011, 34:411-420.
41. Caster J.M., Walker Q.D., Kuhn C.M. Enhanced behavioral response to repeated-dose cocaine in adolescent rats. Psychopharmacology 2005, 183:218-225.
42. Faraday M.M., Elliott B.M., Phillips J.M., Grunberg N.E. Adolescent and adult male rats differ in sensitivity to nicotine's activity effects. Pharmacol Biochem Behav 2003, 74:917-931.
43. Bolanos C.A., Glatt S.J., Jackson D. Subsensitivity to dopaminergic drugs in periadolescent rats: a behavioral and neurochemical analysis. Brain Res Dev Brain Res 1998, 111:25-33.
44. Seeman P., Madras B. Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis. Behav Brain Res 2002, 10:79-83.
45. Tripp G., Wickens J.R. Neurobiology of ADHD. Neuropharmacology 2009, 57:579-589.
46. Crawford C.A., Villafranca S.W., Cyr M.C., Farley C.M., Reichel C.M., Gheorghe S.L., et al. Effects of early methylphenidate exposure on morphine- and sucrose-reinforced behaviors in adult rats: relationship to dopamine D2 receptors. Brain Res 2007, 1139:245-253.
47. Burton C.L., Nobre J.N., Fletcher P.J. The effects of adolescent methylphenidate self-administration on responding for a conditioned reward, amphetamine-induced locomotor activity, and neuronal activation. Psychopharmacology (Berl) 2010, 208:455-468.
48. Achat-Mendes C., Anderson K.L., Itzhak Y. Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood. Neuropharmacology 2003, 45:106-115.
49. Smith R.F. Animal models of periadolescent substance abuse. Neurotoxicol Teratol 2003, 25:291-293.